TOP TIERMARKET NEWSWIRE
News & sentiment

IOVANCE BIOTHERAPEUT (IOVA) — News & AI sentiment

IOVANCE BIOTHERAPEUT (IOVA) news roundup. 7 stories aggregated over the last 30 days. Average 30-day sentiment is 54.9/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
7
avg sentiment 54.9/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on IOVA

Jul 20
Jul 17
Jul 17
Jul 16
Jul 9
Jul 4
Jul 2
Jun 24
Jun 23
Jun 19
Jun 17
Jun 16
Jun 13
Jun 10
Iovance Biotherapeutics: Progress With Caveats
Seeking Alpha38 · neutralgeneral
Jun 10
Jun 7
Jun 6
Jun 5
Jun 4
Jun 3
Jun 1
May 22
May 21
May 11
Iovance Biotherapeutics Q1 Earnings Call Highlights
Yahoo Finance63 · neutralearnings
May 8
Open IOVA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →